Pierce® Streptavidin Agarose Columns
Pierce® Streptavidin UltraLink Resin, Streptavidin Agarose Resin, Streptavidin Agarose
Columns, High Capacity Streptavidin Agarose Resin
1062
0020347 0020349 0020349B 0020351 0020353 0020357 0020359 0020361 0053113
0053114 0053115 0087739 0087740 1883510 1900171 1901691
3/20/2009.
3/20/2009.
Material Safety Data Sheet
Product name
Synonym
Manufacturer
Product No.
MSDS #
Validation date
Print date
In case of emergency
Product and company identification
Responsible name
MSDS (Regulatory Affairs)
:
:
:
:
:
:
:
:
1 .
CHEMTREC:
800.424.9300
OUTSIDE US:
202.483.7616
Supplier
: Thermo Fisher Scientific
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
United States
815.968.0747 or
800.874.3723
:
Use of
Substance/Preparation
Refer to the instruction booklet for
proper and intended use.
Otherwise, contact supplier for
specific applications.
: Thermo Fisher Scientific
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
United States
815.968.0747
800.874.3723
Part of Thermo Fisher Scientific
Dermal contact. Eye contact. Inhalation. Ingestion.
Emergency overview
Hazards identification
Routes of entry
Potential acute health effects
No known significant effects or critical hazards.
No known significant effects or critical hazards.
No known significant effects or critical hazards.
No known significant effects or critical hazards.
Eyes
Skin
Inhalation
Ingestion
Physical state
Liquid. [Gelatinous precipitate.]
CANCER HAZARD - CONTAINS MATERIAL WHICH CAN CAUSE CANCER.
Avoid exposure - obtain special instructions before use. Do not breathe vapor or mist.
Contains material which can cause cancer. Risk of cancer depends on duration and
level of exposure.
:
:
:
:
:
:
:
OSHA/HCS status
: This material is considered hazardous by the OSHA Hazard Communication Standard
(29 CFR 1910.1200).
2 .
Potential chronic health effects
Carcinogenicity
: Contains material which can cause cancer. Risk of cancer depends on duration and
level of exposure.
Mutagenicity
: No known significant effects or critic